NRG4 and metabolic dysfunction-associated steatohepatitis: Overall, NRG4 is a brown fat-derived endocrine checkpoint that exhibits potently protective effects on metabolic disorders in animal models, including insulin resistance, hepatosteatosis, NASH, HCC, and atherosclerosis.